Monoclonetics International, Inc.
Records under this name other than patents Monoclonetics International, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Monoclonetics International, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 4,782,077 | Taliscanin and other aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence Term ended Term ended no later than Nov 1, 2008 · Low confidence | Term ended | Term ended no later than Nov 1, 2008 | Low confidence |
| US 4,940,659 | Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome Term ended Term ended no later than Jul 10, 2010 · Low confidence | Term ended | Term ended no later than Jul 10, 2010 | Low confidence |
| US 5,364,793 | Methods for the diagnosis of peripheral nerve damage Term ended Term ended no later than Nov 15, 2014 · Low confidence | Term ended | Term ended no later than Nov 15, 2014 | Low confidence |
| US 5,583,201 | Methods for diagnosis of peripheral nerve damage Term ended Term ended no later than Dec 10, 2016 · Low confidence | Term ended | Term ended no later than Dec 10, 2016 | Low confidence |
| US 5,844,097 | Methods for the diagnosis of peripheral nerve damage Term ended Term ended no later than Dec 1, 2018 · Low confidence | Term ended | Term ended no later than Dec 1, 2018 | Low confidence |